– New Academic Data Supports Clinical and Commercial Value of Hybrid Imaging Platform- TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) — Conavi Medical Corp. (“Conavi” or the “Company”), a leader in hybrid intravascular imaging technologies, today highlighted the publication of new peer-reviewed research titled “Deep learning-based plaque characterization in hybrid IVUS-OCT images is superior to single-modality […]
Category Archives: Pr Newswire
Pr Newswire
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET
13
Feb
Feb
PRINCETON, N.J., Feb. 13, 2026 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its fourth quarter and full year 2025 financial results on Friday, February 27, 2026, prior to the market open. Nikhil Lalwani, President and Chief Executive Officer, Stephen P. Carey, Senior Vice […]
13
Feb
Feb
ALK (ALKB:DC / OMX: ALK B) will publish its annual report for 2025 in the morning on Friday, 20 February 2026. Later on the same day, the company will host a presentation for investors and analysts at 1:30 p.m. CET, where ALK’s management will comment on the results and outlook and be available for questions. […]
DUBAI, UAE, Feb. 13, 2026 /PRNewswire/ — As Consensus 2026 brings together leaders and changemakers in digital asset innovation, Byreal co-founder Emily Bao today unveiled the protocol’s ambitious 2026 strategic roadmap at Solana Accelerate APAC, illustrating three transformative pillars designed to redefine on-chain trading infrastructure. Speaking at the flagship Solana developer event held during Consensus 2026, […]
BEIJING, Feb. 13, 2026 /PRNewswire/ — As the Chinese New Year of the Horse approaches, sister cities from multiple countries, including Penza in Russia, Le Mans in France and Merri-bek (formerly known as Moreland) in Australia, have extended their festive greetings to Xianyang, a historical city in northwest China’s Shaanxi Province. Original link: https://en.imsilkroad.com/p/349562.html
BEIJING, Feb. 13, 2026 /PRNewswire/ — Hello Group Inc. (NASDAQ: MOMO) (the “Company”), a leading player in Asia’s online social networking space, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025 before U.S. markets open on Wednesday, March 18, 2026. Hello Group’s management will host an earnings conference call […]
HONG KONG, Feb. 13, 2026 /PRNewswire/ — The “2026 Hong Kong International Talents Conference” will be held in Hong Kong on Friday, March 20th. As a satellite event of the “Global Talent Summit Week” held by the Hong Kong Special Administrative Region (HKSAR) Government, the conference is themed “Gather Global Talents, Strengthen Regional Cooperation, Serve National […]
TAIPEI, Feb. 13, 2026 /PRNewswire/ — Catwalk Entertainment Group, the premier Pan-Asian entertainment conglomerate, today announced a strategic partnership with acclaimed Hong Kong director and screenwriter Tze Yiu Chui. The alliance marks a major milestone in Catwalk’s aggressive expansion into international content production, targeting the surging global demand for premium Asian-language screen content. Catwalk Entertainment […]
Pr Newswire
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
13
Feb
Feb
US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million NIAID Funding Award Supports VXV-01 Development Through Phase 1 LIKMEZ® (ATI-1501) Commercial Momentum with Increased U.S. Market Adoption HALIFAX, Nova Scotia, Feb. 12, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug […]
Pr Newswire
Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks
13
Feb
Feb
Approval will broaden the NARCAN® Nasal Spray portfolio, and improve cost-effectiveness by increasing flexibility and distribution efficiency of this life-saving medication GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) — Today, Emergent BioSolutions (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for new multipack configurations of over-the-counter (OTC) NARCAN® Nasal […]